Enzastaurin, a protein kinase Cβ-selective inhibitor, and its potential application as an anticancer agent in lung cancer. Discussion

Saved in:
Bibliographic Details
Published inClinical cancer research Vol. 13; no. 15
Main Authors HERBST, Roy S, OH, Yun, WAGLE, Asavari, LAHN, Michael, LYNCH, Thomas, HEYMACH, John, SANDIER, Alan, BUTTS, Charles, BONOMI, Philip, JOHNSON, Bruce
Format Conference Proceeding
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 2007
Subjects
Antineoplastic agents
Biological and medical sciences
Chemotherapy
Medical sciences
Pharmacology. Drug treatments
Pneumology
Tumors of the respiratory system and mediastinum
Antineoplastic agent
Protein kinase A
Lung disease
Protein kinase C
Respiratory disease
Enzyme
Transferases
Lung cancer
Enzyme inhibitor
Malignant tumor
cAMP-dependent protein kinase
Bronchopulmonary
Bronchus disease
Enzastaurin
Discussion
Online AccessGet full text

Cover

More Information
ISSN:1078-0432
1557-3265